Insider filing · LENZ
Versant Ventures VI GP, L.P. sold $10.1M of LENZ Therapeutics (LENZ)
Executed Jun 18 2025, disclosed Jun 20 2025, 2 days later.
Value, as filed
$10.1M
334,801 sh across 3 lots
Executed
Jun 18 2025
the trade date, as filed
Disclosed
Jun 20 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
VP
Versant Ventures VI GP, L.P.
10% owner
profile →
Versant Ventures VI GP, L.P. (10% owner) filed 1 Form 4 report as a reporting entity in the past 24 months (0 purchases, 1 sale), most often in LENZ Therapeutics, Inc. (LENZ). The largest single filing was $10.1M of LENZ (334,801 sh across 3 lots, as filed), executed Jun 18 2025.
The name
LENZ
LENZ Therapeutics, Inc.
LENZ · Healthcare · 12 filings in 24 months
ticker →
Healthcare · LENZ Therapeutics, Inc. operates as a commercial pharmaceutical company that focuses on the development and commercialization of therapies…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→